Development of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides., PMID:40476553
Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers., PMID:38978164
Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells., PMID:38967656
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector., PMID:38858404
Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status., PMID:38577820
Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion., PMID:38415538
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers., PMID:37104874
Human papillomavirus is an important risk factor for esophageal carcinoma in a Chinese population., PMID:36394699
Usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysis., PMID:35641882
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women., PMID:35351184
A novel recombinant protein vaccine containing the different E7 proteins of the HPV16, 18, 6, 11 E7 linked to the HIV-1 Tat (47-57) improve cytotoxic immune responses., PMID:34313864
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody., PMID:33468698
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial., PMID:33271094
Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank., PMID:33248371
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)., PMID:32816895
Tip60 and p300 function antagonistically in the epigenetic regulation of HPV18 E6/E7 genes in cervical cancer HeLa cells., PMID:32399935
Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18., PMID:32214362
Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma., PMID:32170783
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer., PMID:32151670
Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population., PMID:31860383
Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses' Health Studies., PMID:30894687
A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer., PMID:30770966
Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women., PMID:30755156
Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer., PMID:30353680
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer., PMID:30242022
Prediction and identification of human leukocyte antigen-A2-restricted cytotoxic T lymphocyte epitope peptides from the human papillomavirus 58 E7 protein., PMID:30008894
Bispecific affibody molecule targeting HPV16 and HPV18E7 oncoproteins for enhanced molecular imaging of cervical cancer., PMID:29938318
Serum Immune Profiling for Early Detection of Cervical Disease., PMID:29109779
Generation of affibody molecules specific for HPV16 E7 recognition., PMID:27659535
Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care., PMID:27175798
A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected]., PMID:26242403
Development of chimeric candidate vaccine against HPV18: a proof of concept., PMID:25929429
Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer., PMID:24729277
Peroxiredoxin 3 is a novel marker for cell proliferation in cervical cancer., PMID:24648924
High-risk HPV types and head and neck cancer., PMID:24615247
Anti-HPV-E7 seropositivity and risk of esophageal squamous cell carcinoma in a high-risk population in China., PMID:24356570
Detection of Immunoglobulin G against E7 of Human Papillomavirus in Non-Small-Cell Lung Cancer., PMID:23533408
Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study., PMID:23503618
Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18., PMID:23233027
High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner., PMID:23175360
Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo., PMID:23128977
Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody., PMID:22935825
InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers., PMID:22228147
Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study., PMID:22135254
Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection., PMID:21811748
Combining T-cell vaccination and application of agonistic anti-GITR mAb (DTA-1) induces complete eradication of HPV oncogene expressing tumors in mice., PMID:20145549
Estrogen contributes to non-pRb targeted HPV18 E7-caused cell proliferation and transformation., PMID:20009582
Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients., PMID:19210223
Antibody response for L1, E6, E7 HPV 16, and HPV 18 antigens in Tunisian women with cervical cancer., PMID:19117204
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity., PMID:19095032
For research use only. Not for human or drug use.
